Psilocybin Access Rights
19/11/2025
Our boy Timmy Davis is on the panel|!!!đ
People before profits, patients before patents, equity of safe access to treatment - we can all agree on this, but is it the reality of how the future of psychedelic-assisted therapy is forming? How do we build a psychedelic ecosystem rooted in inclusivity, community care, safety, equity and accessibility in the face of increasing corporatisation and the profit motives and corner-cutting that can often come with it?
We're very happy to be exploring these vital questions and many more with a fantastic collection of speakers on Saturday 22 November, when PsyAware and The Maudsley Psychedelic Society are hosting the event in London and online: 'The Future Is Psychedelic(?): Community, Care, Access, and Resistance'. The event runs from 13:00 to 20:30 (GMT UK). Sign up for your in-person or online ticket here thefutureispsychedelic.eventbrite.co.uk - PsyPAN community members can use the code PSYPAN20 for a 20% discount.
episode of âWhatâs Up Docs?â delivers a fascinating episode with identical twin doctors Chris and Xand van Tulleken. This week, they speak to Dr James Rucker, a consultant psychiatrist at Kingâs College London, about groundbreaking research into psilocybin as a potential treatment for severe depression where other medications have failed. The hosts explore the long history of psychedelic use in medicine and spirituality, from pe**te and ayahuasca to L*D, and discuss the growing scientific optimism for using these substances in treating conditions like anxiety, eating disorders, and addiction. Itâs a thoughtâprovoking listen that blends history, science, and hope for future therapies.
For more info on the PAR (Psilocybin Access Rights) campaign, visit links in bio. #
Click here to claim your Sponsored Listing.
